Literature DB >> 27026369

ESRD Payment Reform: First Do No Harm.

Jenny I Shen1, Keith C Norris2.   

Abstract

Entities:  

Keywords:  Medicare; Payment Reform; anemia; end-stage renal disease

Mesh：

Year:  2016        PMID： 27026369      PMCID： PMC5042679          DOI： 10.1681/ASN.2016020153

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  15 in total

1.  The new label for erythropoiesis stimulating agents: the FDA'S sentence.

Authors:  Steven Fishbane; Kenar D Jhaveri
Journal:  Semin Dial       Date:  2012-04-20       Impact factor: 3.455

2.  Bundled payment for ESRD--including ESAs in Medicare's dialysis package.

Authors:  John K Iglehart
Journal:  N Engl J Med       Date:  2011-02-17       Impact factor: 91.245

3.  The unintended consequences of bundled payments.

Authors:  William B Weeks; Stephen S Rauh; Eric B Wadsworth; James N Weinstein
Journal:  Ann Intern Med       Date:  2013-01-01       Impact factor: 25.391

4.  A path forward on Medicare readmissions.

Authors:  Karen E Joynt; Ashish K Jha
Journal:  N Engl J Med       Date:  2013-03-06       Impact factor: 91.245

5.  Sensitization from transfusion in patients awaiting primary kidney transplant.

Authors:  Julie M Yabu; Matthew W Anderson; Deborah Kim; Brian D Bradbury; Calvin D Lou; Jeffrey Petersen; Jerome Rossert; Glenn M Chertow; Dolly B Tyan
Journal:  Nephrol Dial Transplant       Date:  2013-09-05       Impact factor: 5.992

6.  Major declines in epoetin dosing after prospective payment system based on dialysis facility organizational status.

Authors:  Mae Thamer; Yi Zhang; James Kaufman; Onkar Kshirsagar; Dennis Cotter; Miguel A Hernán
Journal:  Am J Nephrol       Date:  2015-01-10       Impact factor: 3.754

7.  Correction of anemia with epoetin alfa in chronic kidney disease.

Authors:  Ajay K Singh; Lynda Szczech; Kezhen L Tang; Huiman Barnhart; Shelly Sapp; Marsha Wolfson; Donal Reddan
Journal:  N Engl J Med       Date:  2006-11-16       Impact factor: 91.245

8.  Medicare program; end-stage renal disease prospective payment system. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2010-08-12

9.  The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin.

Authors:  A Besarab; W K Bolton; J K Browne; J C Egrie; A R Nissenson; D M Okamoto; S J Schwab; D A Goodkin
Journal:  N Engl J Med       Date:  1998-08-27       Impact factor: 91.245

10.  A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

Authors:  Marc A Pfeffer; Emmanuel A Burdmann; Chao-Yin Chen; Mark E Cooper; Dick de Zeeuw; Kai-Uwe Eckardt; Jan M Feyzi; Peter Ivanovich; Reshma Kewalramani; Andrew S Levey; Eldrin F Lewis; Janet B McGill; John J V McMurray; Patrick Parfrey; Hans-Henrik Parving; Giuseppe Remuzzi; Ajay K Singh; Scott D Solomon; Robert Toto
Journal:  N Engl J Med       Date:  2009-10-30       Impact factor: 91.245
View more
  2 in total

Review 1.  Hemodialysis Disparities in African Americans: The Deeply Integrated Concept of Race in the Social Fabric of Our Society.

Authors:  Keith C Norris; Sandra F Williams; Connie M Rhee; Susanne B Nicholas; Csaba P Kovesdy; Kamyar Kalantar-Zadeh; L Ebony Boulware
Journal:  Semin Dial       Date:  2017-03-09       Impact factor: 3.455

2.  Regional Variations in the Interpretation of the End-Stage Renal Disease Thirty-Month Coordination Period: Potential Implications for Patient Care.

Authors:  Rubette Harford; Mary Jo Clark; Guofen Yan; Jose Flaque; Jose Colon; Francisco Torre; Ylene Rodriguez; Keith C Norris
Journal:  J Health Care Poor Underserved       Date:  2017
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.